Impact of Mitral Stenosis on Survival in Patients Undergoing Isolated Transcatheter Aortic Valve Implantation

This study was performed to investigate the prevalence and impact on survival of baseline mitral stenosis (MS) in patients who underwent transcatheter aortic valve implantation (TAVI) due to the presence of severe symptomatic aortic stenosis. This retrospective study included 928 consecutive patient...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2019-04, Vol.123 (8), p.1314-1320
Main Authors: Sannino, Anna, Potluri, Srinivasa, Pollock, Benjamin, Filardo, Giovanni, Gopal, Ambarish, Stoler, Robert C., Szerlip, Molly, Chowdhury, Anima, Mack, Michael J., Grayburn, Paul A.
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Aortic stenosis
Aortic valve
Aortic Valve - surgery
Aortic Valve Stenosis - complications
Aortic Valve Stenosis - diagnosis
Aortic Valve Stenosis - surgery
Blood pressure
Calcium
Cardiac arrhythmia
Cardiac Catheterization
Chronic obstructive pulmonary disease
Confidence intervals
Coronary artery
Echocardiography
Electrocardiography
Female
Fibrillation
Follow-Up Studies
Heart surgery
Heart valves
Humans
Implantation
Lung diseases
Male
Mercury
Mitral valve
Mitral Valve - diagnostic imaging
Mitral Valve Stenosis - epidemiology
Mitral Valve Stenosis - etiology
Mortality
Obstructive lung disease
Older people
Patients
Population
Prevalence
Retrospective Studies
Risk Factors
Severity of Illness Index
Stenosis
Survival
Survival Rate - trends
Texas - epidemiology
Time Factors
Transcatheter Aortic Valve Replacement
Transplants & implants
Treatment Outcome
Ventricular Function, Left - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study was performed to investigate the prevalence and impact on survival of baseline mitral stenosis (MS) in patients who underwent transcatheter aortic valve implantation (TAVI) due to the presence of severe symptomatic aortic stenosis. This retrospective study included 928 consecutive patients with severe, symptomatic aortic stenosis who underwent TAVI in 2 institutions, from January 2012 to August 2016. Mean follow-up was 40.8 ± 13.9 months. Based on the mean mitral gradient (MMG) at baseline, 3 groups were identified: MMG
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2019.01.017